Cold-Eeze®
Cold-Eeze®, licence 80007128: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Auro Pharma Inc.
- NPN or DIN-HM
- 80007128
- Status
- Active licence
- Licence date
- 15 August 2008
- Revision date
- 12 April 2022
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Saveur de menthe, Alcool éthylique, Saveur de cerise naturel, Eau, Saccharose, miel, Acesulfame-K, Acide ascorbique, essence de citron, Gomme arabique, Sirop de maïs, propylèneglycol, Isomalt, Glycine, Tropical Punch Flavour, Wild Cherry
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | 1.0 Pastille | minimum: 2.0 Heure(s) ; maximum: 4.0 Heure(s) |
| Adultes | Not specified | 1.0 Pastille | minimum: 2.0 Heure(s) ; maximum: 4.0 Heure(s) |
Uses authorised in Canada
Clinically proven to reduce the duration of the symptoms of the common cold. To reduce the duration and severity of the common cold.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
To avoid minor upset stomach upset, do not take Cold-Eeze® Remedy lozenges on an empty stomach. Do not eat or drink citrus fruits or juices 1/2 hour before or after taking Cold-Eeze® Cold Remedy lozenges. Otherwise drink plenty of fluids. Cold-Eeze® Cold Remedy lozenges are formulated to relieve cold symptoms and may be insufficient treatment for influenza. Consult a physician if you taking tetracyclines. If pregnant or breast-feeding, ask a physician before use. May cause diarrhea. May cause mouth and throat irritation. Take a few hours before or after taking other medications.
Source
Official Health Canada record, licence 80007128
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.